Tags

Type your tag names separated by a space and hit enter

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
Kidney Int. 2020 10; 98(4):1054.KI

Authors+Show Affiliations

Internal Medicine Residency Program, Department of Medicine, Medical City Fort Worth, Fort Worth, Texas, USA.Division of Transplant Nephrology, Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA.Division of Transplant Nephrology, Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA. Electronic address: sallam@tarrantnephrology.com.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32650019

Citation

Gade, Akhil R., et al. "Interleukin 6 Levels After Tocilizumab Administration in Transplant Recipients With COVID-19." Kidney International, vol. 98, no. 4, 2020, p. 1054.
Gade AR, Alavala H, Allam SR. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. Kidney Int. 2020;98(4):1054.
Gade, A. R., Alavala, H., & Allam, S. R. (2020). Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. Kidney International, 98(4), 1054. https://doi.org/10.1016/j.kint.2020.06.025
Gade AR, Alavala H, Allam SR. Interleukin 6 Levels After Tocilizumab Administration in Transplant Recipients With COVID-19. Kidney Int. 2020;98(4):1054. PubMed PMID: 32650019.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. AU - Gade,Akhil R, AU - Alavala,Harshitha, AU - Allam,Sridhar R, Y1 - 2020/07/08/ PY - 2020/06/21/received PY - 2020/06/25/revised PY - 2020/06/30/accepted PY - 2020/7/11/pubmed PY - 2020/10/6/medline PY - 2020/7/11/entrez SP - 1054 EP - 1054 JF - Kidney international JO - Kidney Int VL - 98 IS - 4 SN - 1523-1755 UR - https://www.unboundmedicine.com/medline/citation/32650019/Interleukin_6_levels_after_tocilizumab_administration_in_transplant_recipients_with_COVID_19_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0085-2538(20)30803-6 DB - PRIME DP - Unbound Medicine ER -